Alpha Tau Medical
DRTS
14 hedge funds and large institutions have $1.7M invested in Alpha Tau Medical in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 7 closing their positions.
0.23% less ownership
Funds ownership: 1.02% → 0.79% (-0.23%)
22% less funds holding
Funds holding: 18 → 14 (-4)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
81% less capital inflows, than outflows
Capital inflows: $203K | Capital outflows: $1.08M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$83.5K |
| 2 |
Summit Trail Advisors
New York
|
+$42.5K |
| 3 |
Opal Wealth Advisors
Jericho,
New York
|
+$41.4K |
| 4 |
Morgan Stanley
New York
|
+$29K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ETF Managers Group
Summit,
New Jersey
|
-$561K |
| 2 |
Wealthspire Advisors (New York)
New York
|
-$132K |
| 3 |
Fred Alger Management
New York
|
-$131K |
| 4 |
Renaissance Technologies
New York
|
-$111K |
| 5 |
JP Morgan Chase
New York
|
-$65.2K |
DRTS Hedge Fund Activity: Q4 2022 in Review
14 of the 6,243 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q4 2022, worth a combined $1.7M — down 58% from $4.01M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of DRTS and 3 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Fidelity Investments, adding an estimated $83.5K. The largest seller was ETF Managers Group, exiting entirely with an estimated $561K sold.
- 14 institutional investors held Alpha Tau Medical (DRTS) as of Q4 2022, down from 18 in Q3 2022.
- Funds reported $1.7M of Alpha Tau Medical stock for Q4 2022, down 58% quarter-over-quarter.
- 3 funds opened new Alpha Tau Medical positions in Q4 2022 and 7 closed out, a net change of -4 holders.
- The largest Alpha Tau Medical buyer in Q4 2022 was Fidelity Investments, an estimated $83.5K added.
- The largest Alpha Tau Medical seller in Q4 2022 was ETF Managers Group, an estimated $561K sold.
Based on aggregated 13F filings for Q4 2022.